Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : JOURNAL LA MEDIHEALTICO

The Role of Microbiota on the Incidence of Obesity Azzahra, Jihan; Bamahry, Aryanti R; Adnan, Endy
Journal La Medihealtico Vol. 5 No. 2 (2024): Journal La Medihealtico
Publisher : Newinera Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37899/journallamedihealtico.v5i2.1227

Abstract

Obesity is predicted to become a global public health problem, especially in developing countries. Obesity is characterized by a body mass index (BMI) of 30 or more, which is calculated by dividing a person's weight by the square of their height (in kilograms per square meter). The incidence of obesity by age increased from 4.6% in 1980 to 14.0% in 2019. According to the World Health Organization (WHO), around 2 billion adults are classified as overweight, while another 650 million people are categorized as obese. Based on a national survey, the obesity rate in Indonesia is 23.1%, while in South Sulawesi province it is 31.6% (Riskesdas, 2018). This can alter the gut microbiota structurally and functionally, and the gut microbiota can also modulate nutritional status. A certain abundance and diversity of bacteria may facilitate energy storage and metabolic pathways that lead to obesity. Dietary interventions with probiotics, prebiotics, or synbiotics may be effective in counteracting the disturbances observed in the gut microbiota during obesity or unbalanced diets, as they may be able to reduce and maintain body weight. Intestinal anaerobic bacteria, including Firmicute and bacteroids, can hydrolyze carbohydrates that cannot be digested by the intestine, obtaining short chain fatty acids (SCFA) including acetate, propionate and butyrate, which have an impact on human health. Therefore, anaerobic bacteria can inhibit obesity.
Effectiveness of Chronic Disease Management Program in Lowering Blood Pressure in Hypertensive Patients: Literature Review Akbar, Muhammad Alief; Wahid, Syarifuddin; Lestari, Indah; Adnan, Endy; Indarwati, Rezky Putri
Journal La Medihealtico Vol. 5 No. 4 (2024): Journal La Medihealtico
Publisher : Newinera Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37899/journallamedihealtico.v5i4.1606

Abstract

Chronic illnesses are a global health issue that kills people. Hypertension is a blood vessel disorder that compromises the body's tissues' oxygen and nutrient supply. In 2025, 1.5 billion people will have hypertension, and 9.4 million will die from it. This research review evaluates the Chronic Disease Management Program's blood pressure-lowering effects in hypertensive patients. A PRISMA Flow Diagram-based literature review. Downloading scientific papers from PubMed, Portal Garuda, and Google Scholar follows SINTA IV and V criteria. This article searches for Prolanis, blood pressure, and hypertension. Search results yielded 103 articles. Using inclusion criteria, 11 research publications were chosen for review. The study found that the chronic disease management program, which included medical consultations, Prolanis participant education, SMS gateway reminders, home visits, club activities (exercise), and health status monitoring, effectively lowered blood pressure in hypertension patients.